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Abstract. In this study, we investigated which predictors from people with type 1 
diabetes at initiation of intensive treatment that increase the risk of not achieving 
glycemic target. Data from a clinical trial with type 1 diabetes people (n=460) were 
used in a logistic regression model to analyze the effect of the predictors on 
achievement of glycemic target. Results indicate that age, smoking, glycated 
hemoglobin, 1,5-anhydroglucitol and fluctuation from continuous glucose 
monitoring are predictors of achievement of glycemic target, which can be used in 
an algorithm to predict people who fail to achieve glycemic target. 
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1.Introduction 
Today’s guidelines, such as, American Diabetes Association’s Standards of Medical 
Care in Diabetes – 2019[1] recommend intensive treatment for diabetes patients to 
achieve a glycated hemoglobin (HbA1c) level of less than 7% (54 mmol/mol). However, 
it is challenging for people with type 1 diabetes to achieve this glycemic target, and a too 
aggressive treatment increases the risk of severe hypoglycemia[2]. Prediction at 
initiation of intensive treatment of those who will fail to achieve target would enable an 
alternative personalized treatment with the potential of being more effective and safer. 
This study sought to investigate which predictors from people with type 1 diabetes at 
initiation of intensive treatment that increase the risk of not achieving glycemic target. 
2.Method 
Data from people with type 1 diabetes (n=460) enrolled in the Onset 5® trial by Novo 
Nordisk. Participants were on average 43 years old, 57% male, had a diabetes duration 
of 24 years, a body mass index of 26 kg/m2 and an HbA1c of 7.5% (58.5 mmol/L) at 
baseline. 359 (78%) of the participants did not achieve HbA1c < 7% after 16 weeks of 
treatment. Time of randomization defined baseline and initiation of intensive insulin 
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treatment. A logistic regression model was constructed to analyze the effect of a variety 
of predictors at baseline on achievement of HbA1c < 7% (Y/N) after 16 weeks of 
treatment. Predictors at baseline included age (stratified in 18-25, 25-35, 35-50, 50-65 
and >65 years), gender, diabetes duration, body mass index, HbA1c, smoking status, 
fluctuation from continuous glucose monitoring, 1,5-anhydroglycitol (1,5-AG) and 
fasting plasma glucose. Odds ratios (OR) are presented with 95% confidence intervals 
(CI). 
3.Results 
Higher age resulted in an increased risk of not achieving target (50-65 vs 18-25 years 
OR: 3.5, 95% CI: 1.3-9.6). Not surprisingly, higher HbA1c at baseline increased the risk 
as well (OR: 14.7, 95% CI: 7.2-30.0). Being a smoker resulted in a 4-fold increased risk 
of not achieving target (OR: 4.0, 95% CI: 1.2-13.4). Increase in 1,5-AG resulted in a 
decreased risk (OR: 0.89, 95% CI: 0.87-1.01), whereas increased fluctuation in CGM 
increased the risk (OR: 1.34, 95% CI: 0.77-2.33), however, none of them were 
statistically significant. An analysis without fluctuation resulted in a statistically 
significant association between 1,5-AG and achieving glycemic target (OR: 0.87, 95% 
CI: 0.77-0.99). 
4.Discussion 
In this study, higher age affects ability to achieve glycemic target irrespective of diabetes 
duration. Furthermore, being smoker is associated with not achieving target, which is 
confirmed by Peng et al.[3]. Higher 1.5-AG level decreased the risk of not achieving 
target. Blood concentrations of 1,5-AG decreases during time of hyperglycemia, and a 
higher 1,5-AG level at baseline is thus a reflection of a better control with less glycemic 
variability. Furthermore, findings about fluctuation in CGM strengthen the indication of 
glycemic variability as a predictor of achievement of glycemic target. 
5.Conclusion 
Both age, smoking status, HbA1c, 1,5-AG and CGM fluctuation are at baseline for people 
with type 1 diabetes who succeed or fail to achieve glycemic target after 16 weeks of 
treatment. These are valuable findings prior to development of an algorithm to predict 
people who do not achieve glycemic target from intensive insulin treatment where 
alternative treatment options should thus be considered. 
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